Cathay International Holdings Limited is a Hong Kong-based investment holding company. The principal activities of the Company and its subsidiaries are engaging in healthcare business and hotel operations. The Company operates in five segments: Lansen segment, Haizi segment, Yangling segment, Botai segment and Hotel operations segment. The Lansen segment is focused on the manufacture, marketing and sale of specialty western pharmaceuticals, plant extracts and healthcare products and generic pharmaceuticals in the People's Republic of China (PRC). The Haizi segment is engaged in the manufacture, marketing and sale of inositol and its by-product, di-calcium phosphate. The Yangling segment is engaged in the production and sales of plant extracts for use as key active ingredients in healthcare products. The Botai segment is engaged in collagen products. The Hotel operations segment is a hotel located in the Lowu district of Shenzhen in the PRC.